Print

Print


BREATH TEST TO DIAGNOSE PARKINSON'S DISEASE

Nanomedicine [2013] 8 (1) : 43-56 (U.Tisch, I.Schlesinger, R.Ionescu,
M.Nassar, N.Axelrod, D.Robertman, Y. Tessler, F.Azar, A.Marmur,
J.Aharon-Peretz, H.Haick)   Complete abstract

A method of diagnosing Parkinson's Disease has been developed that uses
breath testing. It can identify Parkinson's Disease and Alzheimer's
Disease. Alveolar breath was collected from people with Parkinson's Disease
or Alzheimer's Disease or who had neither. Their breath was analyzed using
sensors (organically functionalized carbon nanotubes and gold
nanoparticles). Statistically significant differences were compared between
the different groups, which was supported by chemical analysis of the
breath samples using gas chromatography combined with mass spectrometry.

The combinations of sensors could distinguish Parkinson's Disease from
healthy states (with an accuracy of 78%), Alzheimer's Disease from healthy
states (with an accuracy of 85%), and Parkinson's Disease from Alzheimer's
Disease (with an accuracy of 84%). Gas chromatography combined with mass
spectrometry analysis was able to show statistically significant
differences in the average level of several volatile organic compounds in
the breath of people with Parkinson's Disease, thus supporting the breath
prints observed with the sensors. The method therefore has future potential
as a cost-effective, fast and reliable means of assisting the diagnosis of
Parkinson's Disease.

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn